Anti-estrogenresistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment

Publisher： Spandidos Publications

E-ISSN： 1791-2431|33|3|1475-1480

ISSN： 1021-335X

Source： Oncology Reports, Vol.33, Iss.3, 2015-01, pp. : 1475-1480

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboplatin treatment of antiestrogen-resistant breast cancer cells

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1863-1870

Spandidos Publications

Access to resources Recommend Favorite

Combination of Ad-sTRAIL with the chemotherapeutic drug cisplatin synergistically enhances their pro-apoptotic ability in human breast cancer cells

By                

Oncology Reports, Vol. 30, Iss. 4, 2013-01 ,pp. : 1913-1919

Spandidos Publications

Access to resources Recommend Favorite

Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 2, 2016-04 ,pp. : 197-214

Bentham Science Publishers

Access to resources Recommend Favorite

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

By Rahman Monzur  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 217-230

Springer Publishing Company

Access to resources Recommend Favorite

Identification of plant extracts sensitizing breast cancer cells to TRAIL

By Abdelhamed Sherif   Yokoyama Satoru   Hafiyani Lia   Kalauni Surya K.   Hayakawa Yoshihiro   Awale Suresh   Saiki Ikuo  

Oncology Reports, Vol. 29, Iss. 5, 2013-05 ,pp. : 1991-1998

Spandidos Publications

Access to resources Recommend Favorite